Dhanvantri Jeevan Rekha Faces Evaluation Adjustment Amidst Flat Financial Performance and Debt Concerns

Feb 19 2025 06:59 PM IST
share
Share Via
Dhanvantri Jeevan Rekha, a player in the Hospital & Healthcare Services sector, has recently experienced a change in evaluation. The company's Q3 FY24-25 results showed stable financial performance, but long-term fundamentals appear weak, with concerns over debt management and a low Return on Equity.
Dhanvantri Jeevan Rekha, operating within the Hospital & Healthcare Services sector, has recently undergone an adjustment in evaluation. This revision reflects the company's underlying financial metrics and market position.

In the latest quarter, Q3 FY24-25, the company reported flat financial performance, indicating stability in its operations. However, the long-term fundamental strength appears to be weak, as evidenced by an average Return on Equity (ROE) of 2.05%. Over the past five years, net sales have shown an annual growth rate of 4.46%, while operating profit has increased at a rate of 8.88%.

The company's ability to manage its debt is also a concern, with a poor EBIT to Interest ratio averaging -0.37. Despite these challenges, Dhanvantri Jeevan Rekha is noted for its attractive valuation, with a Price to Book Value of 0.9, suggesting it is trading at a discount compared to its peers.

Overall, the stock's performance metrics and valuation present a complex picture for stakeholders.

Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
Kanani Industries Ltd is Rated Strong Sell
44 minutes ago
share
Share Via
Shiva Texyarn Ltd is Rated Sell
44 minutes ago
share
Share Via
Riba Textiles Ltd is Rated Sell
44 minutes ago
share
Share Via
Piramal Pharma Ltd is Rated Strong Sell
44 minutes ago
share
Share Via
Infibeam Avenues Ltd is Rated Hold
44 minutes ago
share
Share Via